- Home
- CMND vs NLSP Comparison
CMND vs NLSP Comparison
Compare CMND & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- NLSP
- Stock Information
- Founded
- CMND 2017
- NLSP 2015
- Country
- CMND Canada
- NLSP Switzerland
- Employees
- CMND N/A
- NLSP N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- NLSP Health Care
- Exchange
- CMND Nasdaq
- NLSP Nasdaq
- Market Cap
- CMND 5.3M
- NLSP 5.2M
- IPO Year
- CMND N/A
- NLSP 2021
- Fundamental
- Price
- CMND $1.25
- NLSP $2.10
- Analyst Decision
- CMND
- NLSP
- Analyst Count
- CMND 0
- NLSP 0
- Target Price
- CMND N/A
- NLSP N/A
- AVG Volume (30 Days)
- CMND 65.9K
- NLSP 440.1K
- Earning Date
- CMND 02-05-2025
- NLSP 12-31-2024
- Dividend Yield
- CMND N/A
- NLSP N/A
- EPS Growth
- CMND N/A
- NLSP N/A
- EPS
- CMND N/A
- NLSP N/A
- Revenue
- CMND N/A
- NLSP N/A
- Revenue This Year
- CMND N/A
- NLSP N/A
- Revenue Next Year
- CMND N/A
- NLSP N/A
- P/E Ratio
- CMND N/A
- NLSP N/A
- Revenue Growth
- CMND N/A
- NLSP N/A
- 52 Week Low
- CMND $0.92
- NLSP $1.75
- 52 Week High
- CMND $3.58
- NLSP $24.32
- Technical
- Relative Strength Index (RSI)
- CMND 43.14
- NLSP 22.65
- Support Level
- CMND $1.26
- NLSP $1.75
- Resistance Level
- CMND $1.53
- NLSP $2.13
- Average True Range (ATR)
- CMND 0.09
- NLSP 0.29
- MACD
- CMND -0.00
- NLSP -0.03
- Stochastic Oscillator
- CMND 6.07
- NLSP 4.23
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.